"Adjuvants, Pharmaceutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects.
| Descriptor ID |
D000277
|
| MeSH Number(s) |
D26.650.064 D27.720.744.064
|
| Concept/Terms |
Adjuvants, Pharmaceutic- Adjuvants, Pharmaceutic
- Adjuvant, Pharmaceutical
- Adjuvants, Pharmaceutical
- Pharmaceutical Adjuvants
- Pharmaceutic Adjuvants
- Pharmaceutical Adjuvant
- Adjuvant, Pharmaceutic
- Pharmaceutic Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Adjuvants, Pharmaceutic".
Below are MeSH descriptors whose meaning is more specific than "Adjuvants, Pharmaceutic".
This graph shows the total number of publications written about "Adjuvants, Pharmaceutic" by people in this website by year, and whether "Adjuvants, Pharmaceutic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adjuvants, Pharmaceutic" by people in Profiles.
-
Liu SH, Hunnicutt JN, Ulbricht CM, Dub? CE, Hume AL, Lapane KL. Adjuvant Use and the Intensification of Pharmacologic Management for Pain in Nursing Home Residents with Cancer: Data from a US National Database. Drugs Aging. 2019 06; 36(6):549-557.
-
Iracheta-Vellve A, Petrasek J, Satishchandran A, Gyongyosi B, Saha B, Kodys K, Fitzgerald KA, Kurt-Jones EA, Szabo G. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice. J Hepatol. 2015 Nov; 63(5):1147-55.
-
Cohen AD, Zhou P, Chou J, Teruya-Feldstein J, Reich L, Hassoun H, Levine B, Filippa DA, Riedel E, Kewalramani T, Stubblefield MD, Fleisher M, Nimer S, Comenzo RL. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial. Br J Haematol. 2007 Oct; 139(2):224-33.